Alternatives to Maves

The most polished route to on-label Wegovy or Zepbound, with a dedicated insurance concierge — powerful if the branded product is the goal, though the membership fee and the medication cost are always two separate charges.

• $15/mo cheaper than Maves
• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded

Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.

• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject
• scores 75/100 against Maves's 34

A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject
• scores 81/100 against Maves's 34

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• scores 84/100 against Maves's 34

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject
• scores 80/100 against Maves's 34

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.

• $10/mo cheaper than Maves
• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject